Aim: This meta-analysis aimed to assess the effect of high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) for the treatment of depression in patients with Parkinson's disease (PD).
Methods: The design was a meta-analysis of randomized controlled trials (RCTs). The participants were patients with PD who suffered from depression. The interventions were HF-rTMS alone or in combination with other treatments compared with sham-rTMS, placebo, and anti-depressant treatments. The primary outcome measure was changes in depressive symptoms, defined as the mean change in the total depression score. The secondary outcome was changes in motor symptoms, defined by Unified Parkinson's Disease Rating Scale part III scores, and the acceptability, defined as the risk of all-cause discontinuation. These were expressed as mean differences (MDs), standardized mean differences (SMDs), or risk ratios (RRs) with 95% confidence intervals (CIs).
Results: We identified nine suitable trials, with data from 332 participants. For the patients with depression in PD, HF-rTMS was not better than sham-rTMS (SMD =-0.33, 95% CI -0.83 to 0.17) or selective serotonin re-uptake inhibitors (SSRIs) (SMD =0.07, 95% CI -0.52 to 0.18) for the treatment of depressive symptoms. However, the motor benefits after treatment with HF-rTMS might be better than sham-rTMS (MD =-2.80, 95% CI -5.45 to -0.15) and SSRIs (MD =-2.70, 95% CI -4.51 to -0.90).
Conclusion: This meta-analysis provides some evidence that in patients with PD with depression, HF-rTMS may lead to improvement in motor function but not in depression compared with sham-rTMS or SSRIs.
Keywords: depressive symptoms; motor symptoms; selective serotonin re-uptake inhibitors; sham-repetitive transcranial magnetic stimulation.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in Parkinson disease: a meta-analysis of randomized controlled clinical trials.Neurol Sci. 2015 Oct;36(10):1751-61. doi: 10.1007/s10072-015-2345-4. Epub 2015 Jul 26. Neurol Sci. 2015. PMID: 26209930 Review.
High-frequency repetitive transcranial magnetic stimulation over the primary foot motor area in Parkinson's disease.Brain Stimul. 2013 Nov;6(6):884-91. doi: 10.1016/j.brs.2013.05.002. Epub 2013 May 29. Brain Stimul. 2013. PMID: 23769414 Clinical Trial.
Non-pharmacological treatment for Parkinson disease patients with depression: a meta-analysis of repetitive transcranial magnetic stimulation and cognitive-behavioral treatment.Int J Neurosci. 2020 Apr 7:1-14. doi: 10.1080/00207454.2020.1744591. Online ahead of print. Int J Neurosci. 2020. PMID: 32253965
Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis.JAMA Neurol. 2015 Apr;72(4):432-40. doi: 10.1001/jamaneurol.2014.4380. JAMA Neurol. 2015. PMID: 25686212 Free PMC article. Review.
High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.J Clin Psychiatry. 2013 Feb;74(2):e122-9. doi: 10.4088/JCP.12r07996. J Clin Psychiatry. 2013. PMID: 23473357
- Makkos A, Pál E, Aschermann Z, et al. High-frequency repetitive transcranial magnetic stimulation can improve depression in Parkinson’s disease: A randomized, double-blind, placebo-controlled study. Neuropsychobiology. 2016;73:169–177. - PubMed
- Pal E, Nagy F, Aschermann Z, Balazs E, Kovacs N. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson’s disease: a randomized, double-blind, placebo-controlled study. Mov Disord. 2010;25:2311–2317. - PubMed
- Shin HW, Youn YC, Chung SJ, et al. Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson’s disease. J Neurol. 2016;263:1442–1448. - PubMed
- Wu ZH, Cen HH, Cui LQ, et al. Efficacy studies of high and low frequency repetitive transcranial magnetic stimulation joint sertraline in the treatment of Parkinson’s disease patients with depression. [Accessed December 22, 2017];Mod Diagn Treat. 2013 24:2164–2167. Available from: http://en.cnki.com.cn/Article_en/CJFDTOTAL-XDZD201310005.htm.